{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T12:23:47Z","timestamp":1780316627001,"version":"3.54.1"},"reference-count":19,"publisher":"Georg Thieme Verlag KG","issue":"09","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Dtsch Med Wochenschr"],"published-print":{"date-parts":[[2025,4]]},"DOI":"10.1055\/a-2286-6620","type":"journal-article","created":{"date-parts":[[2025,4,8]],"date-time":"2025-04-08T23:37:16Z","timestamp":1744155436000},"page":"508-520","source":"Crossref","is-referenced-by-count":3,"title":["Rheumatoide Arthritis"],"prefix":"10.1055","volume":"150","author":[{"given":"Jutta","family":"Bauhammer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christoph","family":"Fiehn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"194","published-online":{"date-parts":[[2025,4,8]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"2205","DOI":"10.1056\/NEJMra1004965","article-title":"The pathogenesis of rheumatoid arthritis","volume":"365","author":"IB McInnes","year":"2011","journal-title":"N Engl J Med"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1038\/s41584-022-00827-y","article-title":"Global epidemiology of rheumatoid arthritis","volume":"18","author":"A Finckh","year":"2022","journal-title":"Nat Rev Rheumatol"},{"issue":"S 01","key":"ref3","doi-asserted-by":"publisher","first-page":"S20","DOI":"10.1007\/s00393-022-01302-5","article-title":"Systematic review to estimate the prevalence of inflammatory rheumatic diseases in Germany","volume":"83","author":"A Albrecht","year":"2024","journal-title":"Z Rheumatol"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"100519","DOI":"10.1016\/j.lanepe.2022.100519","article-title":"Rheumatoid arthritis, psoriatic arthritis, and axial spondyloarthritis epidemiology in England from 2004 to 2020: An observational study using primary care electronic health record data","volume":"23","author":"IC Scott","year":"2022","journal-title":"Lancet Reg Health Eur"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"e002777","DOI":"10.1136\/rmdopen-2022-002777","article-title":"Interstitial lung disease in rheumatoid arthritis: incidence, prevalence and related drug prescriptions between 2007 and 2020","volume":"9","author":"K Albrecht","year":"2023","journal-title":"RMD Open"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"e003353","DOI":"10.1136\/rmdopen-2023-003353","article-title":"Prevalence and clinical characteristics of patients with rheumatoid arthritis with interstitial lung disease using unstructured healthcare data and machine learning","volume":"10","author":"JA Rom\u00e1n Ivorra","year":"2024","journal-title":"RMD Open"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1002\/art.42861","article-title":"2023 American College of Rheumatology (ACR)\/American College of Chest Physicians (CHEST) Guideline for the Treatment of Interstitial Lung Disease in People with Systemic Autoimmune Rheumatic Diseases","volume":"76","author":"SR Johnson","year":"2024","journal-title":"Arthritis Rheumatol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2021.102830","article-title":"Efficacy and safety of abatacept in interstitial lung disease of rheumatoid arthritis: A systematic literature review","volume":"20","author":"EF Vicente-Rabaneda","year":"2021","journal-title":"Autoimmun Rev"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1002\/art.38322","article-title":"Methotrexate and lung disease in rheumatoide arthritis: a meta-analysis of randomized controlled trials","volume":"66","author":"R Conway","year":"2014","journal-title":"Arthritis Rheumatol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1136\/rmdopen-2022-002700","article-title":"Comorbidities and treatment patterns in early rheumatoid arthritis: a nationwide Swedish study","volume":"8","author":"L Tidblad","year":"2022","journal-title":"RMD Open"},{"issue":"S 01","key":"ref11","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00393-020-00775-6","article-title":"Management der fr\u00fchen rheumatoiden Arthritis: interdisziplin\u00e4re Leitlinie","volume":"79","author":"M Schneider","year":"2020","journal-title":"Z Rheumatol"},{"issue":"S 02","key":"ref12","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1007\/s00393-018-0481-y","article-title":"S2e-Leitlinie: Behandlung der rheumatoiden Arthritis mit krankheitsmodifizierenden Medikamenten","volume":"77","author":"C Fiehn","year":"2018","journal-title":"Z Rheumatol"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"1580","DOI":"10.1002\/art.27584","article-title":"2010 rheumatoid arthritis classification criteria: an American College of Rheumatology\/European League Against Rheumatism collaborative initiative","volume":"69","author":"D Aletaha","year":"2010","journal-title":"Ann Rheum Dis"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1007\/s00393-022-01308-z","article-title":"Bewertung von Wechselwirkungen und Dosierungsempfehlungen von synthetischen DMARDs \u2013 evidenz- und konsensbasierte Empfehlungen auf Basis einer systematischen Literatursuche","volume":"82","author":"C Fiehn","year":"2023","journal-title":"Z Rheumatol"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1136\/ard-2022-223356","article-title":"EULAR Recommendations for the management of rheumatoid arthritis with synthetic and biological disease modifying antirheumatic drugs: 2022 update","volume":"82","author":"JS Smolen","year":"2023","journal-title":"Ann Rheum Dis"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1002\/art.30129","article-title":"American College of Rheumatology\/European League Against Rheumatism provisional definition of remission in rheumatoid arthritis for clinical trials","volume":"63","author":"DT Felson","year":"2011","journal-title":"Arthritis Rheum"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1056\/NEJMoa2109927","article-title":"Cardiovascular and Cancer Risk with Tofacitinib in Rheumatoid Arthritis","volume":"386","author":"SR Ytterberg","year":"2022","journal-title":"N Engl J Med"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"1524","DOI":"10.1136\/annrheumdis-2011-200726","article-title":"Risk of incident cardiovascular events in patients with rheumatoid arthritis: a meta-analysis of observational studies","volume":"71","author":"JA Avina-Zubieta","year":"2012","journal-title":"Ann Rheum Dis"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"1673","DOI":"10.1136\/annrheumdis-2013-203341","article-title":"Validation of the RABBIT risk score for serious infections","volume":"73","author":"A Zink","year":"2014","journal-title":"Ann Rheum Dis"}],"container-title":["DMW - Deutsche Medizinische Wochenschrift"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/www.thieme-connect.de\/products\/ejournals\/pdf\/10.1055\/a-2286-6620.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,8]],"date-time":"2025-04-08T23:37:29Z","timestamp":1744155449000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.thieme-connect.de\/DOI\/DOI?10.1055\/a-2286-6620"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4]]},"references-count":19,"journal-issue":{"issue":"09","published-online":{"date-parts":[[2025,4,8]]},"published-print":{"date-parts":[[2025,4]]}},"URL":"https:\/\/doi.org\/10.1055\/a-2286-6620","archive":["Portico","CLOCKSS"],"relation":{},"ISSN":["0012-0472","1439-4413"],"issn-type":[{"value":"0012-0472","type":"print"},{"value":"1439-4413","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4]]}}}